# US 2022/0008488 A1 · Probiotics for use in the prevention or treatment of illness and/or symptoms associated with coronaviruses

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0008488 A1
- Document ID: US20220008488A1
- Status: Published application
- Kind: A1
- Application number: 17/240,433
- Filed: 2021-04-26
- Published: 2022-01-13
- Earliest claimed: 2020-07-09
- Assignees: Dupont Nutrition Biosciences Aps
- Applicants: Dupont Nutrition Biosciences Aps
- Inventors: SEBASTIEN GUERY; MARKUS LEHTINEN; SINIKKA ANNELI LATVALA; LIISA LEHTORANTA; BRYAN-JAMES Zabel; WESLEY WILLIAM MOROVIC; CHARLES BUDINOFF; SCOTT D. POWER
- Web page: https://patentgrep.com/patent/US20220008488A1

## CPC

- A61K 35/745: Bifidobacteria
- A61K 35/744: Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61P 31/14: for RNA viruses
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

This invention relates to bacterial strains, compositions comprising bacterial strains as well as methods and uses of said strains and compositions for preventing or treating illness and/or symptoms associated with a coronavirus in a subject in need thereof.

## Claims

### Claim 1

A method of treating illness and/or symptoms associated with coronaviruses in a subject in need thereof, said method comprising administering an effective amount of a composition comprising Bifidobacterium longum subsp. infantis strain Bi-26; Bifidobacterium animalis subsp. lactis strain Bl-04; Lacticaseibacillus paracasei strain Lpc-37; Lacticaseibacillus rhamnosus strain Lr-32 and Ligilactobacillus salivarius strain Ls-33 to said subject, wherein the coronavirus is selected from the group consisting of 229E (alpha coronavirus), NL63 (alpha coronavirus), OC43 (beta coronavirus), HKU1 (beta coronavirus), MERS-CoV (Middle East Respiratory Syndrome coronavirus), SARS-CoV, and SARS-CoV-2 virus.

### Claim 2

(canceled)

### Claim 3 (depends on 1)

The method according to claim 1, wherein said illness is a respiratory illness.

### Claim 4

(canceled)

### Claim 5 (depends on 3)

The method according to claim 3, wherein the respiratory illness is acute respiratory distress syndrome (ARDS).

### Claim 6

(canceled)

### Claim 7 (depends on 3)

The method according to claim 3, wherein the respiratory illness is pneumonia.

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The method according to claim 1, wherein said symptoms are one or more of dyspnea, fatigue, muscle or body aches, nausea or vomiting, diarrhea, cough, fever, anosmia and/or (ageusia.

### Claim 10

(canceled)

### Claim 11 (depends on 1)

The method according to claim 1, wherein said preventing or treating is achieved by stimulation of the immune system in the subject.

### Claim at position 12

12-14. (canceled)

### Claim 15 (depends on 1)

The method according to claim 1, wherein the coronavirus is SARS-CoV-2 virus.

### Claim 16

(canceled)

### Claim 17 (depends on 1)

The method according to claim 1, wherein the subject has one or more pre-existing conditions selected from the group consisting of obesity, type II diabetes, chronic lung disease or moderate to severe asthma, heart conditions, immunocompromised, chronic kidney disease and liver disease.

### Claim 18

(canceled)

### Claim 19 (depends on 1)

The method according to claim 1, wherein the subject is 65 years of age or older and/or is a resident in a nursing home or long-term care facility or jail or prison.

### Claim 20

(canceled)
